Healthpeak Properties announced the execution of long-term leases with Graphite Bio, Inc. and another leading biotech company at its life science development, Nexus on Grand, bringing the project to 100% pre-leased.
Prominently located on East Grand Avenue in the heart of South San Francisco, Nexus on Grand will feature 148,000 square feet of state-of-the-art laboratory and office space and a first-class amenities center to include a café, fitness center, and several indoor and outdoor meeting areas within its entry plaza.
“We are excited to expand our partnerships with two leading biotech companies in our South San Francisco portfolio. The lease-up of our Nexus on Grand project more than a year prior to completion demonstrates the continued market demand for best-in-class, purpose-built lab buildings,” said Scott Bohn, Healthpeak’s Executive Vice President – Co-Head of Life Science in statement.
Nexus on Grand is one of Healthpeak’s three active development projects in the South San Francisco market. The project is currently under construction with an anticipated completion in the second quarter of 2023.
Healthpeak Properties is a fully integrated real estate investment trust and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and CCRCs.
